Showing results (111-120 of 6,005) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|May 20, 2016
Clinical Significance of TLR1 I602S Polymorphism for Patients with Metastatic Colorectal Cancer Treated with FOLFIRI plus BevacizumabSatoshi Okazaki, Fotios Loupakis, Sebastian Stintzing, et al.
Molecular Cancer Therapeutics|May 20, 2016
PAXIP1 Potentiates the Combination of WEE1 Inhibitor AZD1775 and Platinum Agents in Lung CancerAnkita Jhuraney, Nicholas T Woods, Gabriela Wright, et al.
Molecular Cancer Therapeutics|May 20, 2016
NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck CancerLong-Shan Li, Srilakshmi Reddy, Zhen-Hua Lin, et al.
Molecular Cancer Therapeutics|May 20, 2016
Dual Carfilzomib and Doxorubicin-Loaded Liposomal Nanoparticles for Synergistic Efficacy in Multiple MyelomaJonathan D Ashley, Charissa J Quinlan, Valerie A Schroeder, et al.
Molecular Cancer Therapeutics|May 20, 2016
Apratoxin A Shows Novel Pancreas-Targeting Activity through the Binding of Sec 61Kuan-Chun Huang, Zhihong Chen, Yimin Jiang, et al.
Molecular Cancer Therapeutics|May 20, 2016
Triptolide Induces Cell Killing in Multidrug-Resistant Tumor Cells via CDK7/RPB1 Rather than XPB or p44Jun-Mei Yi, Xia-Juan Huan, Shan-Shan Song, et al.
Molecular Cancer Therapeutics|May 20, 2016
Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLCDanielle S Potter, Melanie Galvin, Stewart Brown, et al.
Molecular Cancer Therapeutics|July 14, 2016
BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family MembersSimon J Hogg, Andrea Newbold, Stephin J Vervoort, et al.
Molecular Cancer Therapeutics|July 15, 2016
ATM Mutations in Cancer: Therapeutic ImplicationsMichael Choi, Thomas Kipps, Razelle Kurzrock
Pageof 601